We are live on ! Find out more
KCM

Knoll Capital Management Portfolio holdings

AUM $180M
1-Year Est. Return 66.11%
This Fund
S&P 500
This Quarter Est. Return
+65.96%
1 Year Est. Return
+66.11%
3 Year Est. Return
+268.55%
5 Year Est. Return
+741%
10 Year Est. Return
+10,877.35%
AUM
$57M
AUM Growth
-$251M
Cap. Flow
-$266M
Cap. Flow %
-465.7%
Top 10 Hldgs %
91.01%
Holding
23
New
1
Increased
1
Reduced
1
Closed
5

Top Buys

Rank Stock Value
1
AIXC
AIxCrypto Holdings Inc
AIXC
+$712K
2
LSTA icon
Lisata Therapeutics
LSTA
+$1.13K

Top Sells

Rank Stock Value
1
MDVN
MEDIVATION, INC.
MDVN
+$265M
2
AMPE
Ampio Pharmaceuticals Inc.
AMPE
+$467K
3
EVOK
Evoke Pharma
EVOK
+$381K
4
GLMD icon
Galmed Pharmaceuticals
GLMD
+$224K
5
APTO
Aptose Biosciences, Inc.
APTO
+$29K

Sector Composition

Rank Sector Weight
1 Healthcare 97.16%
2 Technology 1.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRBP icon
1
Corbus Pharmaceuticals
CRBP
$170M
$16.7M 29.31%
85,464
– –
ABEO icon
2
Abeona Therapeutics
ABEO
$345M
$8.04M 14.09%
54,391
– –
TOVX icon
3
Theriva Biologics
TOVX
$10.2M
$6.61M 11.59%
427
– –
NTBL
4
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$4.41M 7.73%
24,589
– –
CEMP
5
DELISTED
Cempra, Inc.
CEMP
$4.32M 7.57%
180,800
– –
ADXS
6
DELISTED
Advaxis Inc
ADXS
$2.86M 5.01%
18,333
– –
ARCT icon
7
Arcturus Therapeutics
ARCT
$157M
$2.8M 4.91%
159,331
– –
VNRX icon
8
VolitionRx Ltd
VNRX
$12M
$2.58M 4.52%
23,077
– –
AMPE
9
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$2.08M 3.65%
9,128
-1,666
-15% -$467K
LUMO
10
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$1.5M 2.64%
11,382
– –
ALDX icon
11
Aldeyra Therapeutics
ALDX
$91.7M
$1.04M 1.82%
135,800
– –
KERX
12
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$1.03M 1.81%
200,000
– –
AIXC
13
AIxCrypto Holdings Inc
AIXC
$16.6M
$869K 1.52%
+4
New +$712K
ADXSW
14
DELISTED
Advaxis Inc Warrants
ADXSW
$750K 1.32%
112,500
– –
NBSE
15
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$568K 1%
513
– –
ENLV icon
16
Enlivex Ltd
ENLV
$70.7M
$424K 0.74%
418
– –
LSTA icon
17
Lisata Therapeutics
LSTA
$15.2M
$266K 0.47%
3,719
+14
+0.4% +$1.13K
CSBR icon
18
Champions Oncology
CSBR
$85.1M
$184K 0.32%
111,111
– –
EVOK
19
DELISTED
Evoke Pharma
EVOK
– –
-387
Closed -$381K
GLMD icon
20
Galmed Pharmaceuticals
GLMD
$3.94M
– –
-277
Closed -$224K
APTO
21
DELISTED
Aptose Biosciences, Inc.
APTO
– –
-27
Closed -$29K
ZSAN
22
DELISTED
Zosano Pharma Corporation
ZSAN
– –
-16
Closed -$15K
MDVN
23
DELISTED
MEDIVATION, INC.
MDVN
– –
-4,397,838
Closed -$265M

Similar funds

MGWA
Monument Group Wealth Advisors Concord, Massachusetts $180M AUM 19.81% 1-Year Est. Return
AW
Alchemi Wealth Essex, Connecticut $180M AUM
FBC
Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return
AIC
Aurora Investment Counsel Atlanta, Georgia $180M AUM 0.3% 1-Year Est. Return
AG
Amiral Gestion Paris, France $180M AUM 9.43% 1-Year Est. Return
PCA
Prospect Capital Advisors Sausalito, California $180M AUM 60.99% 1-Year Est. Return
HIC
Hamrick Investment Counsel Seattle, Washington $180M AUM
FFA
Frazier Financial Advisors Columbus, Ohio $181M AUM 11.16% 1-Year Est. Return

Knoll Capital Management's Q3 2016 Portfolio in Review

As of Q3 2016, Knoll Capital Management held 23 positions worth $57M, down 82% from $309M the previous quarter. Its ten largest holdings account for 91% of the portfolio.

Knoll Capital Management withdrew a net $266M in Q3 2016, closing 5 positions and reducing 1 holding. Its most notable exit was MEDIVATION, INC., an estimated $265M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 14% a quarter earlier, followed by Technology.

Against the trend, Knoll Capital Management opened a new position in AIxCrypto Holdings Inc worth $869K.

  • Knoll Capital Management's largest Q3 2016 buy was AIxCrypto Holdings Inc: 4 shares worth $869K.
  • Knoll Capital Management added most to Lisata Therapeutics in Q3 2016, an estimated $1.13K increase.
  • Knoll Capital Management's biggest Q3 2016 reduction was Ampio Pharmaceuticals Inc., cutting an estimated $467K.
  • Knoll Capital Management fully exited MEDIVATION, INC. in Q3 2016, selling an estimated $265M.
  • Knoll Capital Management's ten largest holdings make up 91% of its $57M portfolio in Q3 2016.
  • Knoll Capital Management opened 1 new position and closed 5 in Q3 2016.
  • Knoll Capital Management's portfolio value fell 82% quarter-over-quarter to $57M.

Based on Knoll Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.